When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
On the AI Stage at TechCrunch Disrupt 2025, Mercor co-founder and CEO Brendan Foody will break down how artificial intelligence is transforming not just how we work, but also who gets to work in the first place.
Vinod Khosla, founder of Khosla Ventures, takes the Disrupt Stage for a candid fireside chat on AI, climate, healthcare, and transformational startups. Hear blunt, big-picture advice from one of tech’s most legendary investors, and learn what founders truly need to succeed in turbulent times.